24時間365日サポート — いつでもお客様をサポートいたします。
お問い合わせ
Seasonal Affective Disorder Market Key Developments, Demand & Forecast Report (2024-2032)
Seasonal Affective Disorder Market Size Was Valued at USD 747.64 Million in 2023, and is Projected to Reach USD 1,185.94 Million by 2032, Growing at a CAGR of 5.26 % From 2024-2032.
IMR
Description
Seasonal Affective Disorder Market Synopsis:
Seasonal Affective Disorder Market Size Was Valued at USD 747.64 Million in 2023, and is Projected to Reach USD 1,185.94 Million by 2032, Growing at a CAGR of 5.26 % From 2024-2032.
SAD is a type of depressive disorder that is marked by recurring episodes at seasonal time of the year particularly during the winter due to reduced natural light. This disorder being characterised by; tiredness, persistent low mood, and a complete and total lack of interest in everything that goes on around an individual. The Seasonal Affective Disorder market is the market of products and services that could help to alleviate the condition, medication, therapy, and changes in life routine. The market also includes implement, instrument, commodity, service and everything else that claims an industrial use aiming at being employed in diagnosing, managing, treating or preventing clinical and nonclinical population by maintaining or minimising a condition.
The global Seasonal Affective Disorder (SAD) market is emerging gradually more and more merely due to the increasing trend of people caring for their mental health concern and the increasing awareness of SAD being a clinical condition which calls for treatment. Some of the causes include new disease triggers especially because of change in climatic conditions, increased stress levels, changes in lifestyles, and reduced exposure to light due to increased elongation of winter seasons. As more and more people learn about how different seasons impact on the mental health of an individual, many patients are seeking rehabilitative remedies ranging from light boxes to drugs and counseling. Such activities foster the enhancement of government interest in encouraging mental health as well as the use of mental health services.
Moreover, development in the treatment techniques has also helped advance the market for SAD treatment technologies. For instance, portable light has been made portable in treatment of depression, treatment of depression has been made through digital therapeutics, psychopharmacological approaches have also experienced progress. There are also more cases of preservation concern, consequently, physicians and mental health professionals are now able to provide unique care depending on patient stimulus. Greater emphasis for research, partnerships with quantity producers, academic and health care institutions are again increasing probabilities for new products.
Seasonal Affective Disorder Market Trend Analysis:
Increasing Adoption of Light Therapy for SAD
Phototherapy is now one of the most used and successful non-pharmacological treatments of SAD. It is used chiefly to cure clients that have SAD because of lack of sunlight especially during winter. This therapy involves exposing the patient to artificial light that resembles natural light is used for synchronization of the body rhythm – circadian rhythm and mood regulation. Individuals are using light therapy products such as light box, light visor, and dawn simulator in the current marked. Fortunately, they are defined and portable in nature, are easily affordable now especially with the advance technology. The opportunities in light therapy which in turn is supported by the availability of such devices are further contributing to the market development across the developed and emergent nations.
Expansion of Mental Health Services and Awareness
As the culture of mental health treatment spreads to different parts of the world there is growing focus on conditions such as seasonal affective disorder. The above-mentioned Governments, health systems and non-governing bodies are putting a better part of their budget in the mental health focused programs which lead to more identification and SAD management. This is a great chance for the companies which work at SAD market, as the main directions to its improvement are education, accessibility of mental health experts and therapy-oriented interventions support. Also, the increased utilization of telemedicine makes another factor for the SAD treatment market because it will be able to reach a patient in a remote area or a patient who cannot physically come to the clinic.
Seasonal Affective Disorder Market Segment Analysis:
Seasonal Affective Disorder Market is Segmented on the basis of Type, Diagnosis, End User, and Region.
By Type, Fall and Winter segment is expected to dominate the market during the forecast period
The nature that the segments are characterised as Fall and Winter has got seasonality where the two dominate the entire year but especially in the forecast period than at any time. This is because SAD is more likely to happen when people are able to get to months which do not get sunshine; this affects the natural circadian clock and serotonin synthesis. These are the best time to diagnose such ailment particularly in those locations where there are months of dark or cold weather. When moving to the next season, the demand for the treatments will rise as more seller’s target products that help minimize effects of the other seasons; The two seasons enjoying the highest market share are still Winter and Fall.
By Diagnosis, Psychological segment expected to held the largest share
The segment for psychological treatment for Seasonal Affective Disorder (SAD) is anticipated to dominate the SAD treatments market throughout the forecast period. A known treatment for SAD is psychotherapy accompanied by other treatments, especially cognitive-behavioral one. This term is used to describe a model of psychotherapy that operates on the inside out- this means that patient thinking and behavioral patterns, the patient’s response to his symptoms and therefore the overall patient state. Since people are developing concern on them and with increased Patient participation in Therapies, the demand for professional psychologist and other psychological services is very likely to increase thus ensuring this segment a market expansion.
Seasonal Affective Disorder Market Regional Insights:
North America is Expected to Dominate the Market Over the Forecast period
North America is anticipated to lead the consumption of Seasonal Affective Disorder (SAD) over the course of the forecast period owing to the factors stated below. The area has witnessed a rising pattern of people suffering from SAD, especially in areas that experience long harsh winters for instance the northern part of US and Canada. The information reveals that as people of North America becomes more aware of mental health and the range of treatments available increases more suffer from SAD and require medical assistance and various treatments such as light therapy, medications and psychotherapy.
Moreover, North America is one of the prime regions in regards to the adventurous activities performed for mental health disorder cure, including seasonal affective disorder cure. Thus, North America came out as the market leader due to the high number of patients and the amount of spending on mental health even if SAD is not an acute problem there. They expect this dominance to be strengthened by increasing healthcare funding and efforts to enhanced availability of mental health support in developing areas.
Active Key Players in the Seasonal Affective Disorder Market
Allergan (Ireland)
Amgen (USA)
AstraZeneca (UK)
Eli Lilly and Company (USA)
F. Hoffmann-La Roche AG (Switzerland)
H. Lundbeck A/S (Denmark)
Johnson & Johnson (USA)
Merck & Co., Inc. (USA)
Mind Media (Netherlands)
Neusoft Medical Systems Co., Ltd. (China)
Noldus Information Technology (Netherlands)
Philips Healthcare (Netherlands)
Siemens Healthineers (Germany)
Takeda Pharmaceutical Company Limited (Japan)
UnitedHealth Group (USA)
Other Active Players.
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Market Dynamics
3.1.1 Drivers
3.1.2 Restraints
3.1.3 Opportunities
3.1.4 Challenges
3.2 Market Trend Analysis
3.3 PESTLE Analysis
3.4 Porter’s Five Forces Analysis
3.5 Industry Value Chain Analysis
3.6 Ecosystem
3.7 Regulatory Landscape
3.8 Price Trend Analysis
3.9 Patent Analysis
3.10 Technology Evolution
3.11 Investment Pockets
3.12 Import-Export Analysis
Chapter 4: Seasonal Affective Disorder Market by Type
4.1 Seasonal Affective Disorder Market Snapshot and Growth Engine
4.2 Seasonal Affective Disorder Market Overview
4.3 Static Mobile
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.3.3 Key Market Trends, Growth Factors and Opportunities
4.3.4 Static Mobile: Geographic Segmentation Analysis
Chapter 5: Seasonal Affective Disorder Market by Application
5.1 Seasonal Affective Disorder Market Snapshot and Growth Engine
5.2 Seasonal Affective Disorder Market Overview
5.3 Cash Management Diamonds
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Cash Management Diamonds: Geographic Segmentation Analysis
5.4 Jewellery & Precious Metals Manufacturing Others
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Jewellery & Precious Metals Manufacturing Others: Geographic Segmentation Analysis
Chapter 6: Seasonal Affective Disorder Market by End User
6.1 Seasonal Affective Disorder Market Snapshot and Growth Engine
6.2 Seasonal Affective Disorder Market Overview
6.3 Financial Institutions Retailers Government Others
6.3.1 Introduction and Market Overview
6.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
6.3.3 Key Market Trends, Growth Factors and Opportunities
6.3.4 Financial Institutions Retailers Government Others: Geographic Segmentation Analysis
Chapter 7: Company Profiles and Competitive Analysis
7.1 Competitive Landscape
7.1.1 Competitive Benchmarking
7.1.2 Seasonal Affective Disorder Market Share by Manufacturer (2023)
7.1.3 Industry BCG Matrix
7.1.4 Heat Map Analysis
7.1.5 Mergers and Acquisitions
7.2 ALLERGAN (IRELAND)
7.2.1 Company Overview
7.2.2 Key Executives
7.2.3 Company Snapshot
7.2.4 Role of the Company in the Market
7.2.5 Sustainability and Social Responsibility
7.2.6 Operating Business Segments
7.2.7 Product Portfolio
7.2.8 Business Performance
7.2.9 Key Strategic Moves and Recent Developments
7.2.10 SWOT Analysis
7.3 AMGEN (USA)
7.4 ASTRAZENECA (UK)
7.5 ELI LILLY AND COMPANY (USA)
7.6 F. HOFFMANN-LA ROCHE AG (SWITZERLAND)
7.7 H. LUNDBECK A/S (DENMARK)
7.8 JOHNSON & JOHNSON (USA)
7.9 MERCK & CO. INC. (USA)
7.10 MIND MEDIA (NETHERLANDS)
7.11 NEUSOFT MEDICAL SYSTEMS CO. LTD. (CHINA)
7.12 NOLDUS INFORMATION TECHNOLOGY (NETHERLANDS)
7.13 PHILIPS HEALTHCARE (NETHERLANDS)
7.14 SIEMENS HEALTHINEERS (GERMANY)
7.15 TAKEDA PHARMACEUTICAL COMPANY LIMITED (JAPAN)
7.16 UNITEDHEALTH GROUP (USA)
7.17 OTHER ACTIVE PLAYERS
Chapter 8: Global Seasonal Affective Disorder Market By Region
8.1 Overview
8.2. North America Seasonal Affective Disorder Market
8.2.1 Key Market Trends, Growth Factors and Opportunities
8.2.2 Top Key Companies
8.2.3 Historic and Forecasted Market Size by Segments
8.2.4 Historic and Forecasted Market Size By Type
8.2.4.1 Static Mobile
8.2.5 Historic and Forecasted Market Size By Application
8.2.5.1 Cash Management Diamonds
8.2.5.2 Jewellery & Precious Metals Manufacturing Others
8.2.6 Historic and Forecasted Market Size By End User
8.2.6.1 Financial Institutions Retailers Government Others
8.2.7 Historic and Forecast Market Size by Country
8.2.7.1 US
8.2.7.2 Canada
8.2.7.3 Mexico
8.3. Eastern Europe Seasonal Affective Disorder Market
8.3.1 Key Market Trends, Growth Factors and Opportunities
8.3.2 Top Key Companies
8.3.3 Historic and Forecasted Market Size by Segments
8.3.4 Historic and Forecasted Market Size By Type
8.3.4.1 Static Mobile
8.3.5 Historic and Forecasted Market Size By Application
8.3.5.1 Cash Management Diamonds
8.3.5.2 Jewellery & Precious Metals Manufacturing Others
8.3.6 Historic and Forecasted Market Size By End User
8.3.6.1 Financial Institutions Retailers Government Others
8.3.7 Historic and Forecast Market Size by Country
8.3.7.1 Russia
8.3.7.2 Bulgaria
8.3.7.3 The Czech Republic
8.3.7.4 Hungary
8.3.7.5 Poland
8.3.7.6 Romania
8.3.7.7 Rest of Eastern Europe
8.4. Western Europe Seasonal Affective Disorder Market
8.4.1 Key Market Trends, Growth Factors and Opportunities
8.4.2 Top Key Companies
8.4.3 Historic and Forecasted Market Size by Segments
8.4.4 Historic and Forecasted Market Size By Type
8.4.4.1 Static Mobile
8.4.5 Historic and Forecasted Market Size By Application
8.4.5.1 Cash Management Diamonds
8.4.5.2 Jewellery & Precious Metals Manufacturing Others
8.4.6 Historic and Forecasted Market Size By End User
8.4.6.1 Financial Institutions Retailers Government Others
8.4.7 Historic and Forecast Market Size by Country
8.4.7.1 Germany
8.4.7.2 UK
8.4.7.3 France
8.4.7.4 The Netherlands
8.4.7.5 Italy
8.4.7.6 Spain
8.4.7.7 Rest of Western Europe
8.5. Asia Pacific Seasonal Affective Disorder Market
8.5.1 Key Market Trends, Growth Factors and Opportunities
8.5.2 Top Key Companies
8.5.3 Historic and Forecasted Market Size by Segments
8.5.4 Historic and Forecasted Market Size By Type
8.5.4.1 Static Mobile
8.5.5 Historic and Forecasted Market Size By Application
8.5.5.1 Cash Management Diamonds
8.5.5.2 Jewellery & Precious Metals Manufacturing Others
8.5.6 Historic and Forecasted Market Size By End User
8.5.6.1 Financial Institutions Retailers Government Others
8.5.7 Historic and Forecast Market Size by Country
8.5.7.1 China
8.5.7.2 India
8.5.7.3 Japan
8.5.7.4 South Korea
8.5.7.5 Malaysia
8.5.7.6 Thailand
8.5.7.7 Vietnam
8.5.7.8 The Philippines
8.5.7.9 Australia
8.5.7.10 New Zealand
8.5.7.11 Rest of APAC
8.6. Middle East & Africa Seasonal Affective Disorder Market
8.6.1 Key Market Trends, Growth Factors and Opportunities
8.6.2 Top Key Companies
8.6.3 Historic and Forecasted Market Size by Segments
8.6.4 Historic and Forecasted Market Size By Type
8.6.4.1 Static Mobile
8.6.5 Historic and Forecasted Market Size By Application
8.6.5.1 Cash Management Diamonds
8.6.5.2 Jewellery & Precious Metals Manufacturing Others
8.6.6 Historic and Forecasted Market Size By End User
8.6.6.1 Financial Institutions Retailers Government Others
8.6.7 Historic and Forecast Market Size by Country
8.6.7.1 Turkiye
8.6.7.2 Bahrain
8.6.7.3 Kuwait
8.6.7.4 Saudi Arabia
8.6.7.5 Qatar
8.6.7.6 UAE
8.6.7.7 Israel
8.6.7.8 South Africa
8.7. South America Seasonal Affective Disorder Market
8.7.1 Key Market Trends, Growth Factors and Opportunities
8.7.2 Top Key Companies
8.7.3 Historic and Forecasted Market Size by Segments
8.7.4 Historic and Forecasted Market Size By Type
8.7.4.1 Static Mobile
8.7.5 Historic and Forecasted Market Size By Application
8.7.5.1 Cash Management Diamonds
8.7.5.2 Jewellery & Precious Metals Manufacturing Others
8.7.6 Historic and Forecasted Market Size By End User
8.7.6.1 Financial Institutions Retailers Government Others
8.7.7 Historic and Forecast Market Size by Country
8.7.7.1 Brazil
8.7.7.2 Argentina
8.7.7.3 Rest of SA
Chapter 9 Analyst Viewpoint and Conclusion
9.1 Recommendations and Concluding Analysis
9.2 Potential Market Strategies
Chapter 10 Research Methodology
10.1 Research Process
10.2 Primary Research
10.3 Secondary Research
Q1: What would be the forecast period in the Seasonal Affective Disorder Market research report?
A1: The forecast period in the Seasonal Affective Disorder Market research report is 2024-2032.
Q2: Who are the key players in the Seasonal Affective Disorder Market?
A2: Allergan (Ireland), Amgen (USA), AstraZeneca (UK), Eli Lilly and Company (USA), F. Hoffmann-La Roche AG (Switzerland), H. Lundbeck A/S (Denmark), Johnson & Johnson (USA), Merck & Co., Inc. (USA), Mind Media (Netherlands), Neusoft Medical Systems Co., Ltd. (China), Noldus Information Technology (Netherlands), Philips Healthcare (Netherlands), Siemens Healthineers (Germany), Takeda Pharmaceutical Company Limited (Japan), UnitedHealth Group (USA), Other Active Players.
Q3: What are the segments of the Seasonal Affective Disorder Market?
A3: The Seasonal Affective Disorder Market is segmented into Type, Diagnosis, End User and Region. By Type, the market is categorized into Fall and Winter Sad Others. By Diagnosis, the market is categorized into Physical Exams Laboratory Tests Psychological Evaluations Others. By End User, the market is categorized into Hospitals Clinics Household Medical Research Centres Others. By region, it is analyzed across North America (U.S., Canada, Mexico), Eastern Europe (Russia, Bulgaria, The Czech Republic, Hungary, Poland, Romania, Rest of Eastern Europe), Western Europe (Germany, UK, France, The Netherlands, Italy, Russia, Spain, Rest of Western Europe), Asia Pacific (China, India, Japan, South Korea, Malaysia, Thailand, Vietnam, The Philippines, Australia, New-Zealand, Rest of APAC), Middle East & Africa (Turkiye, Bahrain, Kuwait, Saudi Arabia, Qatar, UAE, Israel, South Africa), South America (Brazil, Argentina, Rest of SA).
Q4: What is the Seasonal Affective Disorder Market?
A4: SAD is a type of depressive disorder that is marked by recurring episodes at seasonal time of the year particularly during the winter due to reduced natural light. This disorder being characterised by; tiredness, persistent low mood, and a complete and total lack of interest in everything that goes on around an individual. The Seasonal Affective Disorder market is the market of products and services that could help to alleviate the condition, medication, therapy, and changes in life routine. The market also includes implement, instrument, commodity, service, and everything else that claims an industrial use aiming at being employed in diagnosing, managing, treating or preventing clinical and nonclinical populations by maintaining or minimizing a condition.
Q5: How big is the Seasonal Affective Disorder Market?
A5: Seasonal Affective Disorder Market Size Was Valued at USD 747.64 Million in 2023, and is Projected to Reach USD 1,185.94 Million by 2032, Growing at a CAGR of 5.26 % From 2024-2032.
How to buy a report from Megatrends.jp
On the product page, select the license you want: Single User License or Enterprise License.
Select the report language:
- English Report
- English Report + Japanese Translation
Click the Buy Now button.
You’ll be redirected to the checkout page. Enter your company and payment details.
Click Place Order to complete your purchase.
Confirmation: You’ll receive an order confirmation email. Our team will then follow up with your report delivery.
If you have questions, fill out the contact form below or email us at sales1@megatrends.jp.
Thank you for choosing Megatrends.jp!
